Page last updated: 2024-08-21

dexamethasone 21-phosphate and Autoimmune Diseases

dexamethasone 21-phosphate has been researched along with Autoimmune Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brar, B; Higuchi, JW; Higuchi, WI; Papangkorn, K; Prendergast, E1
Ding, Z; Duh, EJ; Eberhart, CG; Ensign, LM; Hanes, J; Hartsock, MJ; Kim, YC; Luo, L; Meng, T; Oh, Y; Stark, WJ; Thorne, JE; Xia, S; Xu, Q; Yang, J1

Other Studies

2 other study(ies) available for dexamethasone 21-phosphate and Autoimmune Diseases

ArticleYear
Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in the Treatment of Experimental Uveitis Rabbit.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2017, Volume: 33, Issue:10

    Topics: Animals; Autoimmune Diseases; Dexamethasone; Disease Models, Animal; Drug Delivery Systems; Glucocorticoids; Panuveitis; Rabbits

2017
Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis.
    Journal of controlled release : official journal of the Controlled Release Society, 2019, 02-28, Volume: 296

    Topics: Administration, Ophthalmic; Adrenal Cortex Hormones; Animals; Autoimmune Diseases; Cytokines; Delayed-Action Preparations; Dexamethasone; Eye; Female; Microglia; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Rats, Inbred Lew; Uveitis; Zinc

2019